Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 18, 2024
TIL Therapy in Lung Cancer: Current Progress and PerspectivesWeilei Hu, Yifei Bian, Hongbin Ji
Cancers|September 9, 2020
Combined Methylome and Transcriptome Analyses Reveals Potential Therapeutic Targets for EGFR Wild Type Lung Cancers with Low PD-L1 ExpressionWeilei Hu, Guosheng Wang, Lonny B Yarmus, et al.
World Journal of Surgical Oncology|June 11, 2016
Effect of adjuvant interferon therapy on hepatitis B virus-related hepatocellular carcinoma: a systematic reviewShu Yang, Qi Lin, Wei Lin, et al.
Frontiers in Immunology|June 20, 2019
Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New OpportunitiesWeilei Hu, Guosheng Wang, Dongsheng Huang, et al.
Frontiers in Genetics|November 16, 2020
Nicotinamide N-Methyltransferase Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric CancerMiaowei Wu, Weilei Hu, Guosheng Wang, et al.
Molecular Cancer|March 31, 2019
Emerging roles and therapeutic value of exosomes in cancer metastasisMiaowei Wu, Guosheng Wang, Weilei Hu, et al.
Iscience|October 21, 2020
Uncoupling Therapeutic Efficacy from Immune-Related Adverse Events in Immune Checkpoint BlockadeWeilei Hu, Guosheng Wang, Yian Wang, et al.
Cancers|October 17, 2019
Cocktail Strategy Based on NK Cell-Derived Exosomes and Their Biomimetic Nanoparticles for Dual Tumor TherapyGuosheng Wang, Weilei Hu, Haiqiong Chen, et al.
Aging|August 29, 2020
Coupled immune stratification and identification of therapeutic candidates in patients with lung adenocarcinomaWeilei Hu, Guosheng Wang, Yundi Chen, et al.
Molecular Oncology|December 18, 2018
Six-gene Assay as a new biomarker in the blood of patients with colorectal cancer: establishment and clinical validationXin Shou, Yong Li, Weilei Hu, et al.
Pageof 2